太极集团部分银行账户解除冻结 涉及金额4292万元

Core Viewpoint - Taiji Group (600129.SH) announced the lifting of the freeze on certain bank accounts of the company and its subsidiary, Southwest Pharmaceutical Co., Ltd., which had been frozen due to a drug sales contract dispute [1] Group 1: Financial Impact - The total amount frozen was 62,921,183.15 yuan, with 20 million yuan related to a dispute with Hangzhou Yueming Pharmaceutical Technology Co., Ltd. and 42,921,183.15 yuan related to a dispute with Tibet Huiye Pharmaceutical Technology Co., Ltd. [1] - The funds related to the dispute with Tibet Huiye Pharmaceutical Technology Co., Ltd. have been fully released, allowing the bank accounts to resume normal operations [1] Group 2: Operational Implications - The freezing of bank accounts did not have a significant impact on the company's main operations during the period [1] - The restoration of normal use of the bank accounts is expected to facilitate the overall fund transfer and usage for the company, ensuring the normal operation of management activities [1]